Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study

Background: The androgen receptor (AR) has emerged as a potential therapeutic target for AR-positive triple-negative breast cancer (TNBC). However, conflicting reports regarding AR’s prognostic role in TNBC are putting its usefulness in question. Some studies conclude that AR positivity indicates a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattarai, Shristi, Klimov, Sergey, Mittal, Karuna, Krishnamurti, Uma, Li, Xiaoxian (Bill), Oprea-Ilies, Gabriela, Wetherilt, Ceyda Sonmez, Riaz, Ansa, Aleskandarany, Mohammed A., Green, Andrew R., Ellis, Ian O., Cantuaria, Guilherme, Gupta, Meenakshi, Manne, Upender, Agboola, Johnson, Baskovich, Brett, Janssen, Emiel A. M., Callagy, Grace, Walsh, Elaine M., Mehta, Anurag, Dogra, Atika, Shet, Tanuja, Gajaria, Pooja, Traina, Tiffany, Nggada, Haruna A., Omonisi, Abidemi, Ahmed, Saad A., Rakha, Emad A., Rida, Padmashree, Aneja, Ritu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678933/
https://www.ncbi.nlm.nih.gov/pubmed/31319547
http://dx.doi.org/10.3390/cancers11070995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678933/
https://www.ncbi.nlm.nih.gov/pubmed/31319547
http://dx.doi.org/10.3390/cancers11070995

Ejemplares similares